The launch follows approval from the Drug Controller General of India (DCGI) for the treatment of type 2 diabetes mellitus and chronic weight management as an adjunct to diet and exercise, based on Phase 3 clinical trials conducted in India
For parenteral use only after admixture with suitable medication
Enhanced Joint Function Patients often report smoother movement, less stiffness, and reduced joint pain making it popular among active adults and those managing arthritis
We manage the entire process, from verifying coverage for semaglutide to submitting prior authorization requests, saving you from navigating complex insurance landscapes alone
You can return home immediately afterward and resume your normal routine
Compounded GLP-1 medications became legally dispensable through licensed pharmacies during periods of FDA-designated drug shortage, opening the door for telehealth platforms like ReadyRx to operate in this space